Risk profile associated with convexity meningioma resection in the modern neurosurgical era.

OBJECT Although meningiomas are commonly found along the supratentorial convexity, the risk profile associated with this subset of lesions in the modern neurosurgical era is unknown. METHODS The authors retrospectively reviewed the clinical course of patients with supratentorial convexity meningiomas treated during the past 10 years. All patients had undergone MR imaging within 72 hours after surgery and at least 1 year of clinical follow-up. Patients with multiple meningiomas, hemangiopericytomas, malignant meningiomas, or tumor-prone syndromes were excluded from analysis. RESULTS Between 1997 and 2007, 141 consecutive patients (median age 48 years, range 18-95 years) underwent resection of a supratentorial convexity meningioma. The most common signs or symptoms at presentation were headache (48%), seizures (34%), and weakness (21%). The mean tumor volume was 146.3 cm3 (range 1-512 cm3). There were no intraoperative complications or deaths. Medical or neurosurgical morbidity was noted in the postoperative course of 14 patients, equating to a 10% overall complication rate. Postoperative surgical complications included hematoma requiring evacuation, CSF leakage, and operative site infection. Medical complications included pulmonary embolus and deep vein thrombosis requiring treatment. A Simpson Grade 0 or 1 resection was achieved in 122 patients (87%). One hundred six tumors (75%) were WHO Grade I, whereas 35 (25%) were WHO Grade II. The median clinical follow-up was 2.9 years (range 1-10 years), and the median radiographic follow-up was 3.7 years (range 1-10 years). Six patients (4%) had radiographic evidence of tumor recurrence, with 3 (2%) undergoing repeat resection. CONCLUSIONS With the conservative recommendations for surgery for asymptomatic meningiomas and the advent of radiosurgery during the past 10 years, microsurgically treated convexity meningiomas are now typically large in size. Nevertheless, the patient's clinical course following microsurgical removal of these lesions is expected to be uncomplicated. The authors' findings provide a defined risk profile associated with the resection of supratentorial convexity meningiomas in the modern neurosurgical era.

[1]  P. Black,et al.  SURGERY FOR CONVEXITY MENINGIOMAS , 2008, Neurosurgery.

[2]  M. McDermott,et al.  Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. , 2008, Neoplasia.

[3]  P. Black,et al.  Surgery for extra-axial tumors of the cerebral convexity and midline. , 2008, Neurosurgery.

[4]  D. Kondziolka,et al.  RADIOSURGERY AS DEFINITIVE MANAGEMENT OF INTRACRANIAL MENINGIOMAS , 2008, Neurosurgery.

[5]  S. Vandenberg,et al.  Molecular signatures define two main classes of meningiomas , 2007, Molecular Cancer.

[6]  M. McDermott,et al.  Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma. , 2007, Journal of neurosurgery.

[7]  K. Zang,et al.  Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters , 2006, Virchows Archiv.

[8]  K. Auguste,et al.  Salvage of infected craniotomy bone flaps with the wash-in, wash-out indwelling antibiotic irrigation system. Technical note and case series of 12 patients. , 2006, Journal of neurosurgery.

[9]  M. Sindou,et al.  Results of attempted radical tumor removal and venous repair in 100 consecutive meningiomas involving the major dural sinuses. , 2006, Journal of neurosurgery.

[10]  J. Kuratsu,et al.  Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. , 2006, Journal of neurosurgery.

[11]  Paolo Cappabianca,et al.  Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors , 2007, Journal of Neuro-Oncology.

[12]  N. Altınörs,et al.  Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas. , 2005, Clinical neuropathology.

[13]  P. Gutin,et al.  Diagnosis and Treatment of Atypical and Anaplastic Meningiomas: A Review , 2005, Neurosurgery.

[14]  S. Lydersen,et al.  Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas. , 2005, Clinical neuropathology.

[15]  M. McDermott,et al.  Meningioma transcript profiles reveal deregulated Notch signaling pathway. , 2005, Cancer research.

[16]  N. Hashimoto,et al.  The combination of mitotic and Ki-67 indices as a useful method for predicting short-term recurrence of meningiomas. , 2004, Surgical neurology.

[17]  Chih‐Yi Hsu,et al.  Histopathology and MIB‐1 labeling index predicted recurrence of meningiomas , 2002, Cancer.

[18]  Shuhua Yang,et al.  Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas , 2001, Journal of Clinical Neuroscience.

[19]  K Arita,et al.  Recurrence of meningiomas , 2000, Cancer.

[20]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[21]  A. Iorio,et al.  Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. , 1998, The New England journal of medicine.

[22]  I. Fonseca,et al.  Clear cell meningioma variant and clinical aggressiveness. , 1998, Clinical neuropathology.

[23]  M. Sindou,et al.  Venous Reconstruction in Surgery of Meningiomas Invading the Sagittal and Transverse Sinuses , 1998, Skull base surgery.

[24]  G. Gillespie,et al.  Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. , 1995, Journal of Neurosurgery.

[25]  D. Figarella-Branger,et al.  Platelet–derived growth factor (PDGF) and receptor (PDGFR) expression in human meningiomas: correlations with clinicopathological features and cytogenetic analysis , 1994, Neuropathology and applied neurobiology.

[26]  M. Cusimano,et al.  Grade zero removal of supratentorial convexity meningiomas. , 1994, Neurosurgery.

[27]  R. Martuza,et al.  Meningioma: analysis of recurrence and progression following neurosurgical resection. , 1985, Journal of neurosurgery.

[28]  S. Giombini,et al.  Late outcome of operations for supratentorial convexity meningiomas. Report on 207 cases. , 1984, Surgical neurology.

[29]  R. Chan,et al.  Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. , 1984, Journal of neurosurgery.

[30]  M. Khan,et al.  The recurrence of intracranial meningiomas after surgical treatment. , 1983, Journal of neurosurgery.

[31]  G. Flyger EPILEPSY FOLLOWING RADICAL REMOVAL OF PARASAGITTAL AND CONVEXITY MENINGIOMAS , 1956, Acta psychiatrica et neurologica Scandinavica.